Daniel Jay Goldman

Title: The Innovations of Daniel Jay Goldman

Introduction

Daniel Jay Goldman is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of neuroscience through his innovative work on neuronal nicotinic acetylcholine receptors. With a total of four patents to his name, Goldman continues to push the boundaries of scientific research and discovery.

Latest Patents

Goldman's latest patents focus on neuronal nicotinic acetylcholine receptor compositions. These inventions relate to a family of receptors comprised of neuronal agonist and non-agonist binding subunits, along with DNA sequences encoding such subunits. The novel receptor subunits include agonist binding subunits alpha2, alpha3, alpha4, and alpha5, as well as non-agonist binding subunits beta2, beta3, and beta4. Representative cDNA clones containing the DNA sequences of these inventions have been deposited with the American Type Culture Collection for patent purposes.

Career Highlights

Goldman is affiliated with the Salk Institute for Biological Studies, where he conducts his research. His work has garnered attention for its potential applications in understanding and treating various neurological conditions. His innovative approach to receptor compositions has positioned him as a key figure in the field.

Collaborations

Goldman has collaborated with notable colleagues, including Stephen Fox Heinemann and James Warner Patrick. These partnerships have further enhanced the impact of his research and contributed to advancements in neuroscience.

Conclusion

Daniel Jay Goldman is a distinguished inventor whose work on neuronal nicotinic acetylcholine receptors has made a significant impact in the field of neuroscience. His innovative patents and collaborations continue to pave the way for future discoveries and advancements.